Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-02

Clinical Trial Update: COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating the effect of colchicine on circulating inflammatory markers after ischemic stroke and in atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: University College Dublin | Conditions: Ischemic Stroke, Atherosclerosis | Phase 2 | Status: UNKNOWN